Anti-BP180 autoantibody titers were significantly higher in the stroke group (19.2 ± 6.07 U/ml) compared to those of control group (12.2 ± 2.39 U/ml; P = 0.024). The gene discussed is COL17A1; the disease is stroke disorder.